Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2003-12-30
2009-06-02
Berch, Mark L (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S260000, C544S323000
Reexamination Certificate
active
07541360
ABSTRACT:
The present invention relates to the area of NO synthase inhibition and, more particularly, relates to novel 4-amino-7,8-dihydropteridines, pharmaceutical compositions containing said compounds, and the use of said compounds in the treatment of a disorder characterized by a disturbed nitric oxide level.
REFERENCES:
patent: 3242178 (1966-03-01), Elion
patent: 4746659 (1988-05-01), DeGraw et al.
patent: 5922713 (1999-07-01), Werner
patent: 44 18 097 (1995-11-01), None
patent: 0 906 913 (1999-04-01), None
patent: 2 240 041 (1991-07-01), None
patent: WO 93/13055 (1993-07-01), None
patent: WO 95/32203 (1995-11-01), None
patent: WO 00/39129 (2000-07-01), None
patent: WO 01/21619 (2001-03-01), None
Christopherson, et al., J. Clin. Invest., vol. 100, No. 10, Nov. 1997, 2424-2429.
Wolfe, et al., Ann. Pharmacother. Jan. 1995; 29(1): 36-46 (abst.).
Akyurek, et al., Am. J. Path., vol. 149, 1981-1990, 1996 (5 page abstract).
Parenti, et al., FASEB. J. (Apr. 27, 2001) 10.1096/fj.00-0503fje.
NIH Medline Plus website, http://www.nlm.nih.gov/medlineplus/ency/article/000170.htm#top, downloaded Feb. 24, 2008.
Nair, Journal of Organic Chemistry (1985), 50(11), 1879-84.
Beilstein Record 1117249, Dated Nov. 29, 1988.
Beilstein Record 5633531, dated Feb. 12, 1993.
Beilstein Record 5613739, Dated Feb. 12, 1993.
McCall, T. B. et al., “Identification of N-Iminoethyl-L-Ornithine as an Irreversible Inhibitor of Nitric Oxide Synthase in Phagocyctic Cells,” Br. J. Pharmacol., vol. 102, No. 1. p. 234, (1991). (Abstract Only).
Misko, T. P. et al., “Selective Inhibition of the Inducible Nitric Oxide Synthase by Aminoguanidine,” Eur. J. Pharmacol., vol. 233, No. 1, p. 119, (1993). (Abstract Only).
Moore, P. K. et al., “7-Nitro Indazole, an Inhibitor of Nitric Oxide Synthase, Exhibits Anti-Nociceptive Activity in the Mouse Without Increasing Blood Pressure,” Br. J. Pharmacol., vol. 108, No. 2, p. 296, (1993). (Abstract Only).
Kwon, N. S. et al., “Reduced Biopterin as a Cofactor in the Generation of Nitrogen Oxides by Murine Macrophages,” The Journal of Biological Chemistry, vol. 264, No. 34, pp. 20496-20501, (1989).
Giovanelli, J. et al., “Tetrhydrobiopterin, a Cofactor for Rat Cerebellar Nitric Does Not Function as a Reactant in the Oxygenation of Arg,” Proc. Natl. Acad. Sci., vol. 88, No. 16, p. 7091, (1991). (Abstract Only).
Mülsch, A. et al., “Nitric Oxide Synthase in Native and Cultured Endothelial Cells: Calcium/Calmodulin and Tetrhdrobiopterin Are Cofactors,” Journal of Cardiovascular Pharmacology, vol. 17, Suppl. 3, pp. S52-S56, (1991).
Sakai, N. et al., “Tetrahydrobiopterin is Required for Cytokine-Induced Nitric Oxide Production in a Murine Macrophage Cell Line (RAW 264),” Mol. Pharmacol., vol. 43, Issue 1, p. 6, (1993). (Abstract Only).
Klatt, P. et al., “Stimulation of Human Nitric Oxide Synthase by Tetrahydrobiopterin and Selective Binding of the Cofactor,” FEBS Letters, vol. 305, No. 2, pp. 160-162, (1992).
Werner-Felmayer, G. et al., “Ca2+/Calmodulin-Dependent Nitric Oxide Synthase Activity in the Human Cervix Carcinoma Cell Line ME-180,” Biochem. J., vol. 289, pp. 357-361, (1993).
Hevel, J. M. et al., “Macrophage Nitric Oxide Synthase: Relationship Between Enzyme-Bound Tetrahydrobiopterin and Synthase Activity,” Biochemistry, vol. 31, pp. 7160-7165, (1992).
Pfeiffer, S. et al., “Allosteric Modulation of Rat Brain Nitric Oxide Synthase by the Pterin-Site Enzyme Inhibitor 4-Aminotetrahydrobiopterin,” Biochem. J., vol. 328, pp. 349-352, (1997).
Werner, E. R. et al., “Identification of the 4-Amino Analoque of Tetrahydrobiopterin as a Dihydropteridine Reductase Inhibitor and a Potent Pteridine Antagonist of Rat Neuronal Nitric Oxide Synthase,” Biochem J., vol. 320, pp. 193-196, (1996).
Schircks, V. B. et al., “A New, Regiospecific Synthesis of L-Biopterine,” Helvetica Chimica Acta, vol. 60, No. 1, pp. 211-214, (1977).
Futterman, S., “Enzymatic Reduction of Folic Acid and Dihydrofolic Acid to Tetrahydro-Folic Acid,” J. Biol. Chem., vol. 228, pp. 1031-1038, (1957). (Abstract Only).
Fukushima, T. et al., “Nuclear Magnetic Resonance Studies of Some Biologically Active Dihydropterins,” vol. 128, Issue 1, 1 page, (1968).
Pfleiderer, W. et al., “A Simple Synthetic Approach to 8-Substituted 5,6,7,8-Tetrathyro- and 7,8-Dihydropterins,” Chem. Ber., vol. 104, pp. 2293-2312, (1971).
Andrews, K. J. M. et al., “A New Synthesis of Biopterin and L-Neopterin,” Chemical Communications, pp. 120-121, (1968).
Hanaya, T. et al., “Pteridines CV Selective N(3)-and O4-Alkylation of L-Biopterin: A Convenient Synthesis of 3-and O4-Methyl-L-Biopterin and the Versatile N2-(N,N-Dimethylaminomethylene)-N(3)-p-Nitrophenethyl-Protected L-Biopterin,” Pteridines, vol. 6, No. 1, pp. 1-7, (1995).
Matter, H. et al., “Structural Requirements for Inhibition of the Neuronal Nitric Oxide synthase (NOS-I): 3D-QSAR Analysis of 4-Oxo-and 4-Amino-Pteridine-Based Inhibitors,” J. Med. Chem., vol. 45, No. 14, pp. 2923-2941, (2002).
Knipp, M. et al., “A Colorimetric 96-Well Microtiter Plate Assay for the Determination of Enzymatically Formed Citrulline,” Anal Biochem., vol. 286, No. 2, pp. 257-264, (2000). (Abstract Only).
Taylor, E. C. et al., “Pteridines. XXIX. An Unequivocal Route to 2,4-Diamino-6-Substituted Pteridines,” Journal of the American Chemical Society, vol. 95, No. 19, pp. 6413-6418, (1973).
Kwee, S. et al., “Electrochemistry of Some Substituted Pteridines,” Biochimica et Biophysica Acta, vol. 297, No. 2, p. 285-296, (1973). (Abstract Only).
Zimmerman, M. et al., “Inhibitors of Folate Biosynthesis. 1. Inhibition of Dihydroneopterin Aldolase by Pteridine Derivatives,” Journal of Medicinal Chemistry, vol. 20, No. 9, pp. 1213-1215, (1977). (Abstract Only).
Al-Hassan et al., “2,4-Diamino-7,8-dihydro-6,7,7-trimethylpteridine;” J. Chem. Soc. Perkin Trans 1, pp. 2145-2150, (1985).
Al-Hassan et al., “2,4-Diamino-8-benzyl-7,8-dihydro-6,7,7-trimethylpteridine,” J. Chem. Soc. Perkin Trans 1, pp. 2145-2150, (1985).
Chaykovsky et al., “6-methyl-7,8-dihydro-pteridine-2,4-diamine,” J. Org. Chem., vol. 40, p. 145, (145).
European Search Report dated Sep. 10, 2007.
Doblhofer Robert
Tegtmeier Frank
Berch Mark L
Finnegan Henderson Farabow Garrett & Dunner L.L.P.
Jaisle Cecilia M
Vasopharm GmbH
LandOfFree
4-amino-7,8-dihydropteridines, pharmaceutical compositions... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 4-amino-7,8-dihydropteridines, pharmaceutical compositions..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 4-amino-7,8-dihydropteridines, pharmaceutical compositions... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4130409